Hearing Review·Industry news·Business & finance·3d agoCilcare Updates License Agreement with Sanofi, Brings Pharma Giant on as Equity HolderSanofi's deepened investment in Cilcare's hearing-loss pipeline reflects growing pharmaceutical industry confidence that drug-based treatments for hearing loss are commercially viable.
Hearing Health Matters·Press release·Business & finance·8d agoSanofi Takes Equity Stake in Cilcare as Hearing Therapeutics Partnership ExpandsA major pharma player deepening its financial commitment to hearing therapeutics signals growing industry confidence that drug-based treatments for hearing loss may reach the clinic within the coming years.＋Save
Hearing Health Matters·Press release·Tinnitus·8w agoCilcare Expands U.S. Operations with CBSET Partnership and Planned Tinnitus Trial at Mass General HospitalA planned clinical trial for a novel tinnitus drug candidate at a major academic center signals growing pharmaceutical investment in tinnitus treatment, an area with no currently approved pharmacological therapy.＋Save
Hearing Review·Industry news·Tinnitus·8w agoCilcare Announces US Clinical Trial for Tinnitus Drug, Expands Research CapacityTinnitus has no FDA-approved pharmacological treatment, making any credible drug entering human trials a significant milestone for the field.＋Save
